180 related articles for article (PubMed ID: 28314734)
1. FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia.
Cheng CK; Wang AZ; Wong THY; Wan TSK; Cheung JS; Raghupathy R; Chan NPH; Ng MHL
Blood; 2017 May; 129(19):2705-2709. PubMed ID: 28314734
[No Abstract] [Full Text] [Related]
2. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
[TBL] [Abstract][Full Text] [Related]
3. Acute promyelocytic leukaemia (APML) with cryptic PML-RARA fusion has a clinical course comparable to classical APML with t(15;17)(q24.1;q21.2) translocation.
Greenfield G; Michail O; Merron B; McGimpsey J; Catherwood M; McMullin MF
Br J Haematol; 2019 Jul; 186(1):155-157. PubMed ID: 30585303
[No Abstract] [Full Text] [Related]
4. The leukemic oncoprotein NPM1-RARA inhibits TP53 activity.
Swaney EM; Chattopadhyay A; Abecassis I; Rush EA; Redner RL
Leuk Lymphoma; 2016 Aug; 57(8):1933-7. PubMed ID: 26754533
[TBL] [Abstract][Full Text] [Related]
5. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
Chen Y; Li S; Zhou C; Li C; Ru K; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang B; Wang M; Wang J
Blood; 2014 Aug; 124(6):936-45. PubMed ID: 24782508
[TBL] [Abstract][Full Text] [Related]
6. A novel t(3;17)(p25;q21) variant translocation of acute promyelocytic leukemia with rearrangement of the RARA locus.
Redner RL; Contis LC; Craig F; Evans C; Sherer ME; Shekhter-Levin S
Leukemia; 2006 Feb; 20(2):376-9. PubMed ID: 16341036
[No Abstract] [Full Text] [Related]
7. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.
Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR
Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel recurrent
Yao L; Wen L; Wang N; Liu T; Xu Y; Ruan C; Wu D; Chen S
Blood; 2018 Feb; 131(8):935-939. PubMed ID: 29237593
[No Abstract] [Full Text] [Related]
9. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia.
Yamamoto Y; Tsuzuki S; Tsuzuki M; Handa K; Inaguma Y; Emi N
Blood; 2010 Nov; 116(20):4274-83. PubMed ID: 20807888
[TBL] [Abstract][Full Text] [Related]
10. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia.
Jiang M; Wang X; Yu M; Jiang S; Hong M; Zhou Y; Li F; Liu H; Zhang Z
Am J Hematol; 2024 May; 99(5):1005-1007. PubMed ID: 38410879
[TBL] [Abstract][Full Text] [Related]
11. Novel reciprocal fusion genes involving
Su Z; Liu X; Xu Y; Hu W; Zhao C; Zhao H; Feng X; Zhang S; Yang J; Shi X; Peng J
Haematologica; 2020 Jul; 105(7):e376-e378. PubMed ID: 32354871
[No Abstract] [Full Text] [Related]
12. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia.
Jovanovic JV; Chillón MC; Vincent-Fabert C; Dillon R; Voisset E; Gutiérrez NC; Sanz RG; Lopez AA; Morgan YG; Lok J; Solomon E; Duprez E; Díaz MG; Grimwade D
Leukemia; 2017 Mar; 31(3):747-751. PubMed ID: 27872498
[No Abstract] [Full Text] [Related]
13. Characterization of a cryptic
Schultz MJ; Blackburn PR; Cogbill CH; Pitel BA; Smadbeck JB; Johnson SH; Vasmatzis G; Rech KL; Sukov WR; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Leuk Lymphoma; 2020 Apr; 61(4):975-978. PubMed ID: 31809670
[No Abstract] [Full Text] [Related]
14. [Variant acute promyelocytic leukemia with IRF2BP2-RARA fusion gene: a case report and literature review].
Wu CY; Yang SW; Li YL; Dong XY; Yu RH; Zhang L; Shang BJ; Shi PL; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):251-254. PubMed ID: 37356989
[No Abstract] [Full Text] [Related]
15. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.
Wen L; Xu Y; Yao L; Wang N; Wang Q; Liu T; Pan J; Cen J; Zhou H; Miao M; Shao YW; Wang X; Wang X; Ruan C; Wu D; Chen S
Haematologica; 2019 May; 104(5):e195-e199. PubMed ID: 30237272
[No Abstract] [Full Text] [Related]
16. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
17. Cryptic insertion of PML-RARA into the 3p25 locus in an acute promyelocytic leukemia with t(3;17)(p25;q21).
Chattopadhyay A; Redner RL
Cancer Genet Cytogenet; 2010 Aug; 201(1):28-31. PubMed ID: 20633765
[TBL] [Abstract][Full Text] [Related]
18. TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid.
Chong ML; Cheng H; Xu P; You H; Wang M; Wang L; Ho HH
Leuk Res; 2018 Nov; 74():51-54. PubMed ID: 30292835
[No Abstract] [Full Text] [Related]
19. Cytogenetically cryptic and fish negative PML/RARA rearrangement in acute promyelocytic leukemia detected by RT-PCR.
Avgerinou G; Katsibardi Κ; Filippidou M; Tzanoudaki M; Papadhimitriou SI; Kattamis A
Leuk Lymphoma; 2020 Dec; 61(14):3526-3528. PubMed ID: 32909480
[No Abstract] [Full Text] [Related]
20. The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia.
Yang X; Zhang R; Zhang Z
Ann Hematol; 2022 Sep; 101(9):2101-2102. PubMed ID: 35704083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
